课题基金 / 基金详情

Co-operation between GATA2 mutation or expression and RAS signalling in AML

Co-operation between GATA2 mutation or expression and RAS signalling in AML
AML 中 GATA2 突变或表达与 RAS 信号传导之间的合作
批准号:
nhmrc : 1086302
负责人:
A/Pr Ian Lewis
金额:
$57.38万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Ian Lewis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have identified a gene GATA2 which, when mutated, can lead to leukaemia (blood cancer). We will collect samples worldwide from families and individuals that carry GATA2 mutations and have developed leukaemia, and will screen for other genetic changes that contribute to leukaemia. We have also identified a novel group of patients who have a low GATA2 activity and who also have mutations in the RAS gene, a known contributor to leukaemia. We will determine how these cooperate to cause leukaemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mab immunotherapies for myeloid leukemia patients with germline or somatic RUNX1 mutations.
  • 批准号:
    nhmrc : GNT1145278
  • 项目类别:
    Project Grants
  • 资助金额:
    $76.7万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Ian Lewis
  • 依托单位:
Mab immunotherapies for myeloid leukemia patients with germline or somatic RUNX1 mutations.
  • 批准号:
    nhmrc : 1145278
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.86万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Ian Lewis
  • 依托单位:
FANC gene mutations in Acute Myeloid Leukaemia biology and treatment
  • 批准号:
    nhmrc : 1145391
  • 项目类别:
    Project Grants
  • 资助金额:
    $60.9万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Ian Lewis
  • 依托单位:
FANC gene mutations in Acute Myeloid Leukaemia biology and treatment
  • 批准号:
    nhmrc : GNT1145391
  • 项目类别:
    Project Grants
  • 资助金额:
    $90.08万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Ian Lewis
  • 依托单位:
海外基金